InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: None

Tuesday, 07/27/2021 11:52:57 AM

Tuesday, July 27, 2021 11:52:57 AM

Post# of 13741
National Library of Medicine: Cytotoxic Effects of Blue Scorpion Venom (Rhopalurus junceus) in a Glioblastoma Cell Line Model
Laura A Lozano-Trujillo et al. Curr Pharm Biotechnol. 2021.

https://pubmed.ncbi.nlm.nih.gov/32679017/
Abstract

Background: Cancer is one of the leading cause of death worldwide. Besides current therapies and treatments to counter cancer, new alternatives are required to diminish the cell proliferation of oncogenic processes.

Methods: One of the most promissory therapy includes the use of blue scorpion venom as a specific cytotoxic agent to kill tumoral cells, including Glioblastoma multiforme.

Objectives: We show evidence of the cytotoxic effect of blue scorpion venom in a cellular model of Glioblastoma multiforme.

Results: Our results demonstrate that 50 µg/ml of scorpion venom is capable to diminish the viability of Glioblastoma populations.

Conclusion: It is possible that the action mechanism could be associated with a loss of membrane integrity. Additionally, some metalloproteinases as MMP2 and MMP9 may also participate in the potential action mechanism.

Keywords: Rhopalurus junceus; blue scorpion; cancer.; cytotoxic effects; glioblastoma; venom.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.